Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Mod Pathol. 2010 Jan 15;23(5):743–750. doi: 10.1038/modpathol.2009.189

Figure 5.

Figure 5

Disease-specific survival of GIST patients categorized according to the CA II or c-KIT (CD117) immunostaining results. Positive reactions for KIT and strong staining for CA II indicated significantly better survival rates.